New England Journal of Medicine, volume 391, issue 18, pages 1696-1708

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma

Christian U. Blank ¹

Minke W. Lucas ¹

Richard A. Scolyer ¹

Bart A. van de Wiel ¹

Alexander M. Menzies ¹

Marta Lopez-Yurda ¹

Lotte L Hoeijmakers ¹

Robyn P.M. Saw ¹

Judith M Lijnsvelt ¹

Nigel G. Maher ¹

Saskia M Pulleman ¹

Gonzalez Maria ¹

Alejandro Torres Acosta ¹

Winan J. Van Houdt ¹

Serigne N. Lo ¹

Anke M J Kuijpers ¹

Andrew Spillane ¹

W. Martin C. Klop ¹

Thomas E. Pennington ¹

Charlotte L. Zuur ¹

Kerwin F. Shannon ¹

Beatrijs A. Seinstra ¹

Robert V. Rawson ¹

John B.A.G. Haanen ¹

Sydney Ch’ng ¹

Kishan A T Naipal ¹

Jonathan Stretch ¹

Johannes V. van Thienen ¹

Michael A. Rtshiladze ¹

Sofie Wilgenhof ¹

Rony Kapoor ¹

Aafke Meerveld-Eggink ¹

Lindsay G. Grijpink-Ongering ¹

Alexander C.J. van Akkooi ¹

Irene L M Reijers ¹

David E. Gyorki ¹

Dirk J. Grünhagen ¹

Frank M Speetjens ¹

Sonja B. Vliek ¹

Joanna Placzke ¹

Lavinia Spain ¹

Robert C Stassen ¹

Mona Amini-Adle ¹

Céleste Lebbé ¹

Mark B. Faries ¹

Caroline Robert ¹

Paolo A. Ascierto ¹

Rozemarijn van Rijn ¹

Franchette W. P. J. van den Berkmortel ¹

Djura Piersma ¹

Andre van der Westhuizen ¹

Gerard Vreugdenhil ¹

Maureen J.B. Aarts ¹

Marion A. M. Stevense‐den Boer ¹

Victoria Atkinson ¹

Muhammad Khattak ¹

Miles C Andrews ¹

Alfons J.M. van den Eertwegh ¹

Marye J. Boers-Sonderen ¹

Geke A.P. Hospers ¹

Matteo S. Carlino ¹

Jan-Willem B. de Groot ¹

Ellen Kapiteijn ¹

Karijn P.M. Suijkerbuijk ¹

Piotr Rutkowski ¹

Shahneen Sandhu ¹

Astrid A.M. van der Veldt ¹

Georgina V. Long ¹

Show full list: 68 authors

Hide authors affiliations

From the Departments of Medical Oncology (C.U.B., M.W.L., L.L.H., J.M.L., S.M.P., J.B.A.G.H., K.A.T.N., J.V.T., S.W., A.M.-E., I.L.M.R.), Pathology (B.A.W.), Biometrics (M.L.-Y., A.T.A., L.G.G.-O.), Surgical Oncology (W.J.H., A.M.J.K., A.C.J.A.), Head and Neck Surgery (W.M.C.K., C.L.Z.), Radiology (B.A.S.), and Molecular Oncology and Immunology (J.B.A.G.H.), Netherlands Cancer Institute, and the Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer...

Publication type: Journal Article

Publication date: 2024-11-07

Massachusetts Medical Society

Journal: New England Journal of Medicine

scimago Q1

SJR: 20.544

CiteScore: 145.4

Impact factor: 96.2

ISSN: 00284793, 15334406

DOI: 10.1056/nejmoa2402604

Copy DOI

PubMed ID: 38828984

Found

	1 2 3 4 5 6
Journal for ImmunoTherapy of Cancer	Journal for ImmunoTherapy of Cancer, 6, 5% Journal for ImmunoTherapy of Cancer 6 publications, 5%
Nature Reviews Clinical Oncology	Nature Reviews Clinical Oncology, 5, 4.17% Nature Reviews Clinical Oncology 5 publications, 4.17%
European Journal of Cancer	European Journal of Cancer, 5, 4.17% European Journal of Cancer 5 publications, 4.17%
Cancer Cell	Cancer Cell, 4, 3.33% Cancer Cell 4 publications, 3.33%
EJC Skin Cancer	EJC Skin Cancer, 4, 3.33% EJC Skin Cancer 4 publications, 3.33%
Cancers	Cancers, 4, 3.33% Cancers 4 publications, 3.33%
Surgical Clinics of North America	Surgical Clinics of North America, 4, 3.33% Surgical Clinics of North America 4 publications, 3.33%
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 4, 3.33% International Journal of Molecular Sciences 4 publications, 3.33%
Annals of Oncology	Annals of Oncology, 3, 2.5% Annals of Oncology 3 publications, 2.5%
Surgical Oncology Clinics of North America	Surgical Oncology Clinics of North America, 3, 2.5% Surgical Oncology Clinics of North America 3 publications, 2.5%
Expert Review of Anticancer Therapy	Expert Review of Anticancer Therapy, 3, 2.5% Expert Review of Anticancer Therapy 3 publications, 2.5%
Expert Opinion on Biological Therapy	Expert Opinion on Biological Therapy, 3, 2.5% Expert Opinion on Biological Therapy 3 publications, 2.5%
Frontiers in Immunology	Frontiers in Immunology, 3, 2.5% Frontiers in Immunology 3 publications, 2.5%
The Lancet Oncology	The Lancet Oncology, 2, 1.67% The Lancet Oncology 2 publications, 1.67%
Nature Medicine	Nature Medicine, 2, 1.67% Nature Medicine 2 publications, 1.67%
Journal of Surgical Oncology	Journal of Surgical Oncology, 2, 1.67% Journal of Surgical Oncology 2 publications, 1.67%
European Journal of Surgical Oncology	European Journal of Surgical Oncology, 2, 1.67% European Journal of Surgical Oncology 2 publications, 1.67%
Annals of Surgical Oncology	Annals of Surgical Oncology, 2, 1.67% Annals of Surgical Oncology 2 publications, 1.67%
American Journal of Surgery	American Journal of Surgery, 2, 1.67% American Journal of Surgery 2 publications, 1.67%
ESMO Open	ESMO Open, 2, 1.67% ESMO Open 2 publications, 1.67%
Deutsche Medizinische Wochenschrift	Deutsche Medizinische Wochenschrift, 2, 1.67% Deutsche Medizinische Wochenschrift 2 publications, 1.67%
Critical Reviews in Oncology/Hematology	Critical Reviews in Oncology/Hematology, 1, 0.83% Critical Reviews in Oncology/Hematology 1 publication, 0.83%
hautnah	hautnah, 1, 0.83% hautnah 1 publication, 0.83%
Immunotherapy	Immunotherapy, 1, 0.83% Immunotherapy 1 publication, 0.83%
Acta Clinica Belgica	Acta Clinica Belgica, 1, 0.83% Acta Clinica Belgica 1 publication, 0.83%
European urology oncology	European urology oncology, 1, 0.83% European urology oncology 1 publication, 0.83%
Nature Cancer	Nature Cancer, 1, 0.83% Nature Cancer 1 publication, 0.83%
Journal of Clinical Oncology	Journal of Clinical Oncology, 1, 0.83% Journal of Clinical Oncology 1 publication, 0.83%
Die Dermatologie	Die Dermatologie, 1, 0.83% Die Dermatologie 1 publication, 0.83%
	1 2 3 4 5 6

	5 10 15 20 25 30 35 40 45
Elsevier	Elsevier, 45, 37.5% Elsevier 45 publications, 37.5%
Springer Nature	Springer Nature, 24, 20% Springer Nature 24 publications, 20%
Taylor & Francis	Taylor & Francis, 12, 10% Taylor & Francis 12 publications, 10%
MDPI	MDPI, 10, 8.33% MDPI 10 publications, 8.33%
BMJ	BMJ, 6, 5% BMJ 6 publications, 5%
Wiley	Wiley, 4, 3.33% Wiley 4 publications, 3.33%
Frontiers Media S.A.	Frontiers Media S.A., 4, 3.33% Frontiers Media S.A. 4 publications, 3.33%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 3, 2.5% Ovid Technologies (Wolters Kluwer Health) 3 publications, 2.5%
Georg Thieme Verlag KG	Georg Thieme Verlag KG, 2, 1.67% Georg Thieme Verlag KG 2 publications, 1.67%
American Society of Clinical Oncology (ASCO)	American Society of Clinical Oncology (ASCO), 1, 0.83% American Society of Clinical Oncology (ASCO) 1 publication, 0.83%
American Chemical Society (ACS)	American Chemical Society (ACS), 1, 0.83% American Chemical Society (ACS) 1 publication, 0.83%
Oxford University Press	Oxford University Press, 1, 0.83% Oxford University Press 1 publication, 0.83%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 1, 0.83% Cold Spring Harbor Laboratory 1 publication, 0.83%
Walter de Gruyter	Walter de Gruyter, 1, 0.83% Walter de Gruyter 1 publication, 0.83%
Impact Journals	Impact Journals, 1, 0.83% Impact Journals 1 publication, 0.83%
SAGE	SAGE, 1, 0.83% SAGE 1 publication, 0.83%
American College of Physicians	American College of Physicians, 1, 0.83% American College of Physicians 1 publication, 0.83%
Society for Translational Oncology	Society for Translational Oncology, 1, 0.83% Society for Translational Oncology 1 publication, 0.83%
American Medical Association (AMA)	American Medical Association (AMA), 1, 0.83% American Medical Association (AMA) 1 publication, 0.83%
	5 10 15 20 25 30 35 40 45

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST | RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1056/nejmoa2402604

UR - http://www.nejm.org/doi/10.1056/NEJMoa2402604

TI - Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma

T2 - New England Journal of Medicine

AU - Blank, Christian U.

AU - Lucas, Minke W.

AU - Scolyer, Richard A.

AU - van de Wiel, Bart A.

AU - Menzies, Alexander M.

AU - Lopez-Yurda, Marta

AU - Hoeijmakers, Lotte L

AU - Saw, Robyn P.M.

AU - Lijnsvelt, Judith M

AU - Maher, Nigel G.

AU - Pulleman, Saskia M

AU - Maria, Gonzalez

AU - Torres Acosta, Alejandro

AU - Van Houdt, Winan J.

AU - Lo, Serigne N.

AU - Kuijpers, Anke M J

AU - Spillane, Andrew

AU - Klop, W. Martin C.

AU - Pennington, Thomas E.

AU - Zuur, Charlotte L.

AU - Shannon, Kerwin F.

AU - Seinstra, Beatrijs A.

AU - Rawson, Robert V.

AU - Haanen, John B.A.G.

AU - Ch’ng, Sydney

AU - Naipal, Kishan A T

AU - Stretch, Jonathan

AU - van Thienen, Johannes V.

AU - Rtshiladze, Michael A.

AU - Wilgenhof, Sofie

AU - Kapoor, Rony

AU - Meerveld-Eggink, Aafke

AU - Grijpink-Ongering, Lindsay G.

AU - van Akkooi, Alexander C.J.

AU - Reijers, Irene L M

AU - Gyorki, David E.

AU - Grünhagen, Dirk J.

AU - Speetjens, Frank M

AU - Vliek, Sonja B.

AU - Placzke, Joanna

AU - Spain, Lavinia

AU - Stassen, Robert C

AU - Amini-Adle, Mona

AU - Lebbé, Céleste

AU - Faries, Mark B.

AU - Robert, Caroline

AU - Ascierto, Paolo A.

AU - van Rijn, Rozemarijn

AU - van den Berkmortel, Franchette W. P. J.

AU - Piersma, Djura

AU - van der Westhuizen, Andre

AU - Vreugdenhil, Gerard

AU - Aarts, Maureen J.B.

AU - Stevense‐den Boer, Marion A. M.

AU - Atkinson, Victoria

AU - Khattak, Muhammad

AU - Andrews, Miles C

AU - van den Eertwegh, Alfons J.M.

AU - Boers-Sonderen, Marye J.

AU - Hospers, Geke A.P.

AU - Carlino, Matteo S.

AU - de Groot, Jan-Willem B.

AU - Kapiteijn, Ellen

AU - Suijkerbuijk, Karijn P.M.

AU - Rutkowski, Piotr

AU - Sandhu, Shahneen

AU - van der Veldt, Astrid A.M.

AU - Long, Georgina V.

PY - 2024

DA - 2024/11/07

PB - Massachusetts Medical Society

SP - 1696-1708

IS - 18

VL - 391

PMID - 38828984

SN - 0028-4793

SN - 1533-4406

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2024_Blank,

author = {Christian U. Blank and Minke W. Lucas and Richard A. Scolyer and Bart A. van de Wiel and Alexander M. Menzies and Marta Lopez-Yurda and Lotte L Hoeijmakers and Robyn P.M. Saw and Judith M Lijnsvelt and Nigel G. Maher and Saskia M Pulleman and Gonzalez Maria and Alejandro Torres Acosta and Winan J. Van Houdt and Serigne N. Lo and Anke M J Kuijpers and Andrew Spillane and W. Martin C. Klop and Thomas E. Pennington and Charlotte L. Zuur and Kerwin F. Shannon and Beatrijs A. Seinstra and Robert V. Rawson and John B.A.G. Haanen and Sydney Ch’ng and Kishan A T Naipal and Jonathan Stretch and Johannes V. van Thienen and Michael A. Rtshiladze and Sofie Wilgenhof and Rony Kapoor and Aafke Meerveld-Eggink and Lindsay G. Grijpink-Ongering and Alexander C.J. van Akkooi and Irene L M Reijers and David E. Gyorki and Dirk J. Grünhagen and Frank M Speetjens and Sonja B. Vliek and Joanna Placzke and Lavinia Spain and Robert C Stassen and Mona Amini-Adle and Céleste Lebbé and Mark B. Faries and Caroline Robert and Paolo A. Ascierto and Rozemarijn van Rijn and Franchette W. P. J. van den Berkmortel and Djura Piersma and others},

title = {Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma},

journal = {New England Journal of Medicine},

year = {2024},

volume = {391},

publisher = {Massachusetts Medical Society},

month = {nov},

url = {http://www.nejm.org/doi/10.1056/NEJMoa2402604},

number = {18},

pages = {1696--1708},

doi = {10.1056/nejmoa2402604}

}

MLA

Found error?

Publisher

Massachusetts Medical Society

Journal

New England Journal of Medicine

scimago Q1

SJR

20.544

CiteScore

145.4

Impact factor

96.2

ISSN

00284793

15334406

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma

Top-30

Journals

Publishers

Are you a researcher?